Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128586) titled 'A randomized clinical controlled trial of the combined treatment of probiotics and recombinant human growth hormone for idiopathic short stature' on July 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jingdezhen Second People's Hospital
Condition:
Idiopathic short stature
Intervention:
Probiotic group:rhGH basic treatment + Lactobacillus Josii combined with Lactococcus lactis subspecies complex probiotics for auxiliary intervention.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Probiotic group:50;Placebo group:50; ...